List of Studies ( Metabolite:PG 35:1)
| Study_id | Analysis_id | Study_title | Source | Species | Disease | Institute | Analysis Type |
|---|---|---|---|---|---|---|---|
| ST003661 | AN006018 | Lipidomics facilitates the discovery of diagnostic biomarkers in patients with chronic total occlusion during the perioperative period | Blood | Human | Cardiovascular disease | Zhongshan Hospital Fudan University | LC-MS |
| ST003565 | AN005858 | Metaboloomics analysis of the antimalarial compound WEHI-1888504 (aka compound 59) in Plasmodium falciparum (3D7) infected red blood cells | Cultured cells | Plasmodium falciparum | Malaria | Monash University | LC-MS |
| ST003246 | AN005317 | Effects of mitoregulin loss on cardiac and mitochondrial lipids in aged male mice | Heart | Mouse | Cardiovascular disease | University of Iowa | LC-MS |
| ST003179 | AN005222 | Property and Activity Refinement of Dihydroquinazolinone-3-carboxamides as Orally Efficacious Antimalarials that Target PfATP4 | Plasmodium cells | Plasmodium falciparum | Malaria | Monash University | LC-MS |
| ST003053 | AN005007 | Providing insight into the mechanism of action of Cationic Lipidated Oligomers (CLOs) using metabolomics | Bacterial cells | Staphylococcus aureus | Bacterial infection | Monash University | LC-MS |
| ST003051 | AN005003 | Shotgun lipidomics of breast cancer endocrine therapy persisters | Breast cancer cells | Human | Cancer | Dartmouth College | LC-MS |
| ST003036 | AN004978 | Identifying and mathematically modeling the time-course of extracellular metabolic markers associated with resistance to ceftolozane/tazobactam in Pseudomonas aeruginosa - Part 2 | Bacterial cells | Pseudomonas aeruginosa | Bacterial infection | Monash Institute of Pharmaceutical Sciences | LC-MS |
| ST002890 | AN004748 | Characterization of the in vivo deuteration of native phospholipids by mass spectrometry yields guidelines for their regiospecific customization | Bacterial cells | Escherichia coli | University of Tennessee | LC-MS | |
| ST002522 | AN004156 | Lipidomics study on the effect of LBP protein on hepatic lipid composition in mice | Liver | Mouse | Oxidative stress | University of Science and Technology of China | LC-MS |
| ST001859 | AN003013 | dTor affects the fat body lipidome via Nep1r1, Ctdnep1 and Lipin | Insect tissue | Fruit fly | VIB-KU Leuven | MS(Dir. Inf.) | |
| ST001859 | AN003014 | dTor affects the fat body lipidome via Nep1r1, Ctdnep1 and Lipin | Insect tissue | Fruit fly | VIB-KU Leuven | MS(Dir. Inf.) | |
| ST001067 | AN001747 | Lipidomics analysis for aged mice femoral muscle (part - IV) | Adipose tissue | Mouse | Takeda Pharmaceutical Company Limited | LC-MS | |
| ST001067 | AN001747 | Lipidomics analysis for aged mice femoral muscle (part - IV) | Brain | Mouse | Takeda Pharmaceutical Company Limited | LC-MS | |
| ST001067 | AN001747 | Lipidomics analysis for aged mice femoral muscle (part - IV) | Liver | Mouse | Takeda Pharmaceutical Company Limited | LC-MS | |
| ST001067 | AN001747 | Lipidomics analysis for aged mice femoral muscle (part - IV) | Muscle | Mouse | Takeda Pharmaceutical Company Limited | LC-MS | |
| ST001066 | AN001745 | Lipidomics analysis for aged mice liver (part-III) | Adipose tissue | Mouse | Takeda Pharmaceutical Company Limited | LC-MS | |
| ST001066 | AN001745 | Lipidomics analysis for aged mice liver (part-III) | Brain | Mouse | Takeda Pharmaceutical Company Limited | LC-MS | |
| ST001066 | AN001745 | Lipidomics analysis for aged mice liver (part-III) | Liver | Mouse | Takeda Pharmaceutical Company Limited | LC-MS | |
| ST001066 | AN001745 | Lipidomics analysis for aged mice liver (part-III) | Muscle | Mouse | Takeda Pharmaceutical Company Limited | LC-MS | |
| ST001065 | AN001743 | Lipidomics analysis for aged mice brain cortex (part-II) | Adipose tissue | Mouse | Takeda Pharmaceutical Company Limited | LC-MS | |
| ST001065 | AN001743 | Lipidomics analysis for aged mice brain cortex (part-II) | Brain | Mouse | Takeda Pharmaceutical Company Limited | LC-MS | |
| ST001065 | AN001743 | Lipidomics analysis for aged mice brain cortex (part-II) | Liver | Mouse | Takeda Pharmaceutical Company Limited | LC-MS | |
| ST001065 | AN001743 | Lipidomics analysis for aged mice brain cortex (part-II) | Muscle | Mouse | Takeda Pharmaceutical Company Limited | LC-MS | |
| ST001063 | AN001740 | Lipidomics analysis for aged mice organs | Adipose tissue | Mouse | Takeda Pharmaceutical Company Limited | LC-MS | |
| ST001063 | AN001740 | Lipidomics analysis for aged mice organs | Brain | Mouse | Takeda Pharmaceutical Company Limited | LC-MS | |
| ST001063 | AN001740 | Lipidomics analysis for aged mice organs | Liver | Mouse | Takeda Pharmaceutical Company Limited | LC-MS | |
| ST001063 | AN001740 | Lipidomics analysis for aged mice organs | Muscle | Mouse | Takeda Pharmaceutical Company Limited | LC-MS | |
| ST000842 | AN001358 | Muscle and plasma before and after exercise | Blood | Human | Obesity | University of Michigan | LC-MS |
| ST000841 | AN001351 | Metabolomics of muscle in insulin sensitive and resistant obese indivduals. | Muscle | Human | Obesity | University of Michigan | LC-MS |
| ST000778 | AN001230 | Rat Colon Study effect of Effect of fish oil on azoxymethane (AOM) | Colon | Rat | University of Michigan | LC-MS | |
| ST000753 | AN001181 | Comparison of the metabolome and lipidome of wild type and mdx/mTR mice | Muscle | Mouse | University of Michigan | LC-MS | |
| ST000679 | AN001044 | Functional genomics study on Non Alcoholic fatty liver disease (NAFLD) - part II | Cultured cells | Human | Fatty liver disease | University of Michigan | LC-MS |
| ST000671 | AN001028 | LCR/HCR rat mitochondrial study | Mitochondria | Rat | University of Michigan | LC-MS | |
| ST000666 | AN001018 | Rat Rotator Cuff Lipidomics | Muscle | Rat | University of Michigan | LC-MS |
